Litcius/Paper detail

Combination therapy with immune checkpoint inhibitors in advanced renal cell carcinoma: A meta-analysis of randomized controlled trials

Dun‐Chang Mo, Jianfeng Huang, Peng‐Hui Luo, Shang‐Xiao Huang, Han‐Lei Wang

2021Clinical Immunology21 citationsDOI

Topics & Concepts

MedicineInternal medicineOncologyHazard ratioRenal cell carcinomaAdverse effectRandomized controlled trialMeta-analysisCombination therapyCochrane LibraryOdds ratioProgression-free survivalConfidence intervalChemotherapyRenal cell carcinoma treatmentCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis
Combination therapy with immune checkpoint inhibitors in advanced renal cell carcinoma: A meta-analysis of randomized controlled trials | Litcius